Qatar Home Healthcare Market Size To Worth USD 3.6 Billion By 2033 | CAGR of 7.7%

Qatar Home Healthcare Market Overview

Market Size in 2024: USD 1.7 Billion

Market Size in 2033: USD 3.6 Billion

Market Growth Rate 2025-2033: 7.7%

According to IMARC Group's latest research publication, "Qatar Home Healthcare Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the Qatar home healthcare market size reached USD 1.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.7% during 2025-2033.

How AI is Reshaping the Future of Qatar Home Healthcare Market

● Qatar's Digital Agenda 2030 pumps $2.5 billion into AI for healthcare, making home monitoring a breeze with wearables that spot issues early and cut hospital trips by up to 30%, just like the SIHA platform does for personalized check-ins.

● Teaming up with Scale AI, Qatar's government is rolling out smart chatbots and voice agents that slash admin time in home care by 40%, letting nurses focus more on patients and less on paperwork for smoother daily routines.

● With 90% of Qatar's CEOs jumping on generative AI, home healthcare firms are using it to predict needs and customize plans, boosting patient satisfaction scores by 25% through tailored advice right from your living room.

● The National Skilling Program trains 50,000 folks in AI basics, empowering home health teams to handle tools that flag fraud in claims with 92% accuracy, saving providers millions while keeping care trustworthy and efficient.

● Backed by Qatar National Vision 2030, AI wearables and telehealth apps are transforming home recovery for chronic cases, reducing avoidable readmissions by 36% and making quality care feel accessible no matter where you are.

Grab a sample PDF of this report: https://www.imarcgroup.com/qatar-home-healthcare-market/requestsample

Market Growth Factors

Qatar's home healthcare market is experiencing robust growth driven by a rapidly aging population and the escalating prevalence of chronic diseases such as diabetes and cardiovascular conditions, which necessitate continuous monitoring and personalized care outside traditional hospital settings. According to the Qatar Public Health Strategy, these non-communicable diseases are becoming increasingly common, with projections indicating that nearly 19.44% of the population will be affected by diabetes by 2025, fueling demand for convenient, home-based interventions that enhance patient comfort and independence. This demographic shift, combined with a high-income populace prioritizing quality of life, positions home healthcare as a vital component of the nation's evolving medical ecosystem, projected to expand from USD 1.7 billion in 2024 to USD 3.6 billion by 2033 at a CAGR of 7.7%.

The integration of advanced digital technologies, including telehealth and remote patient monitoring, is revolutionizing Qatar's home healthcare landscape by enabling efficient virtual consultations and real-time health data tracking, particularly accelerated by the COVID-19 pandemic's legacy of a 300% surge in telehealth adoption. Under the National Health Strategy 2024-2030, government initiatives are promoting digital transformation to improve accessibility and efficiency, with the smart hospitals and digital health market already valued at USD 1.2 billion and telemedicine services forecasted to reach QAR 1.2 billion soon. These innovations not only reduce the burden on overburdened facilities but also empower patients with proactive care management, aligning with Qatar's ambition to become a regional healthcare hub through tech-driven solutions.

Substantial government investments and supportive policies, exemplified by a QR22 billion allocation to healthcare in the 2025 national budget-representing 10.5% of total expenditure-are propelling the home healthcare sector forward by fostering public-private partnerships and infrastructure enhancements tailored to in-home services. This financial commitment, part of the broader Qatar National Vision 2030, underscores a strategic push toward sustainable, patient-centered care models that leverage PPPs to add capacity and expertise, ultimately driving total health expenditure to USD 12.9 billion by 2029 at a CAGR of 13.6%. Such policy-driven momentum not only attracts international players but also ensures equitable access to high-quality home-based treatments amid rising private health spending.

Purchase the 2026 Comprehensive Updated data: https://www.imarcgroup.com/checkout?id=24066&method=1179

Market Segmentation

Product Insights:

● Therapeutic Products
● Testing, Screening, and Monitoring Products
● Mobility Care Products

Service Insights:

● Skilled Nursing
● Rehabilitation Therapy
● Hospice and Palliative Care
● Unskilled Care
● Respiratory Therapy
● Infusion Therapy
● Pregnancy Care

Indication Insights:

● Cancer
● Respiratory Diseases
● Movement Disorders
● Cardiovascular Diseases and Hypertension
● Pregnancy
● Wound Care
● Diabetes
● Hearing Disorders
● Others

Regional Insights:

● Ad Dawhah
● Al Rayyan
● Al Wakrah
● Others

Recent Developement & News

● November 2025: Qatar Medicare 2025 exhibition highlights AI and IoT integration in smart hospitals, drawing 100 companies to showcase remote monitoring tech that cuts patient wait times by 30% in home-based care.

● November 2025: Health Hackathon 2025 launches with over 200 participants developing wearables and digital health solutions for preventive care, targeting a 25% rise in home-based chronic disease management via AI-driven apps.

● January 2025: Telemedicine platforms expand in home healthcare, supported by QR22 billion budget allocation, enabling 40% more virtual consultations for remote patients using secure video and sensor-linked devices.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302

This release was published on openPR.